Grant: Team Grant: Mucosal Immunology for HIV Vaccine Development
McMaster University
$180,000.00
Interaction between sex hormones, microbiome and innate immunity in the female reproductive tract: Impact mucosal immunity and HIV susceptibility
FY 2014-15
Summary
Clinical and experimental studies have shown that sex hormones and hormonal contraceptives can directly and indirectly affect susceptibility to HIV. The interactions between sex hormones, microbiome and innate immunity in the reproductive tract have not been studied in great detail. Yet this information is critical to understanding how susceptibility to HIV is altered with menstrual cycle, hormonal contraceptives, changes in microbiome associated with BV and in women of different ethnicities. All these factors interact and alter innate inflammation in female genital tract which is critical in shaping the T cell immunity. This knowledge is critical for successfully inducing protective immune responses in the reproductive tract.
In this application we propose to address comprehensively, the interactions between sex hormones and the microbiome-innate immunity axis and its effects on mucosal immunity in the female genital tract. The proposal will address this by a) conducting a clinical study to examine the effect of hormonal contraceptives in a Kenyan cohort where there is very high use of Depo-Provera, the progesterone based formulation which has been consistently correlated with increased susceptibility and transmission b) examining whether local alteration of local microenvironment in the FRT by either estrogen and/or probiotic treatment will decrease innate inflammation and subsequently alter the phenotype of mucosal T cells c) conduct mechanistic studies in a gnotobiotic humanized mouse model to establish a cause-effect relationship between sex hormones-microbiome and the inflammatory environment and T cell repertoire and HIV infection in the FRT and whether specific strains of lactobacilli can alter the mucosal environment and decrease susceptibility to HIV and d) by determining at a cellular level the effect of hormones, lactobacilli and HIV on the transcriptome of genital epithelial cells, the primary cells that initiate immune responses in the FRT.
Department
Program
Team Grant: Mucosal Immunology for HIV Vaccine Development
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
312321
Name
Kaushic Charu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Bill & Melinda Gates Foundation
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Mucosal Immunology for HIV Vaccine Development
Projecttitle
Interaction between sex hormones, microbiome and innate immunity in the female reproductive tract: Impact mucosal immunity and HIV susceptibility
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$180,000
Cihrequipment2
$0
Programname2
Team Grant: Mucosal Immunology for HIV Vaccine Development
Keyworddelim
Estrogen Therapy; Female Sex Hormones; Hiv Susceptibility; Innate Immunity; Microbiome; Mucosal Immunity; Probiotics
Abstract
Clinical and experimental studies have shown that sex hormones and hormonal contraceptives can directly and indirectly affect susceptibility to HIV. The interactions between sex hormones, microbiome and innate immunity in the reproductive tract have not been studied in great detail. Yet this information is critical to understanding how susceptibility to HIV is altered with menstrual cycle, hormonal contraceptives, changes in microbiome associated with BV and in women of different ethnicities. All these factors interact and alter innate inflammation in female genital tract which is critical in shaping the T cell immunity. This knowledge is critical for successfully inducing protective immune responses in the reproductive tract.
In this application we propose to address comprehensively, the interactions between sex hormones and the microbiome-innate immunity axis and its effects on mucosal immunity in the female genital tract. The proposal will address this by a) conducting a clinical study to examine the effect of hormonal contraceptives in a Kenyan cohort where there is very high use of Depo-Provera, the progesterone based formulation which has been consistently correlated with increased susceptibility and transmission b) examining whether local alteration of local microenvironment in the FRT by either estrogen and/or probiotic treatment will decrease innate inflammation and subsequently alter the phenotype of mucosal T cells c) conduct mechanistic studies in a gnotobiotic humanized mouse model to establish a cause-effect relationship between sex hormones-microbiome and the inflammatory environment and T cell repertoire and HIV infection in the FRT and whether specific strains of lactobacilli can alter the mucosal environment and decrease susceptibility to HIV and d) by determining at a cellular level the effect of hormones, lactobacilli and HIV on the transcriptome of genital epithelial cells, the primary cells that initiate immune responses in the FRT.
Competitiondate
201406
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kaushic, Charu; Tharao, Wangari E; Ashkar, Ali A; Fowke, Keith R; Smaill, Fiona M; Surette, Michael G
Approvedterm
3 ans 0 mois
Cihrcontribution2
HIV/AIDS~ $180,000~ $0~